SlideShare a Scribd company logo
1 of 42
Analysis and Interpretation: Overview ,[object Object],[object Object],[object Object],[object Object],[object Object]
Framework for synthesis ,[object Object],[object Object],[object Object],[object Object],[object Object]
Why Perform a Meta-analysis? ,[object Object],[object Object],[object Object],[object Object],[object Object]
More on Meta-analysis ,[object Object],[object Object],[object Object],[object Object],[object Object]
When not Appropriate to do M/a ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Dichotomous Measures ,[object Object],[object Object],[object Object],[object Object]
Risk ratio (RR)  aka relative risk RR =   a / (a+b)  c / (c+d) Risk/ probability/ chance  of the occurrence of an event in treatment relative to control Intervention Control a+b=n I c+d=n C Event No event d c b a
Sample RR Calculation Death No death RR =   14/133  =  0.11  = 0.13 128/148  0.86 Drug 133 148 Placebo 20 128 119 14
Odds ratio (OR) Intervention Control No event Event OR =  a / b  c / d  Odds of an event occurring to it not occurring for treatment relative to control a+b=n I c+d=n C d c b a
Sample OR Calculation Death No death Drug Placebo 133 148 OR =   14/119  =  0.12  = 0.019 128/20  6.4 20 128 119 14
Interpreting (for intervention) Increased odds (harmful) Increased odds  (beneficial) OR>1 (6.4/0.12) Reduced odds (beneficial) Reduced odds (not beneficial) OR<1 (0.12/6.4) No difference No difference OR=1, RR=1 Increased risk (harmful) Increased risk  (beneficial) RR>1 (0.86/0.11) Reduced risk  (beneficial) Reduced risk (not beneficial) RR<1 (0.11/0.86) Bad outcome  (e.g. infection) Good outcome (e.g. remission)
RR vs. OR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Closer Look at Odds RR = 0.11 / 0.86 = 0.13 ↑ A rate (11%) OR = 0.12 / 6.4  = 0.019 ↑ ~1:9 ↑ ~7:1
Absolute Effect Measures ,[object Object],[object Object]
Risk Difference (RD) Death No death Actual difference in  risk of events Placebo Drug 133 148 RD = 14/133 – 128/148 = 0.11 – 0.86 = - 0.75 20 128 119 14
Risk Difference (RD)  (continued) ,[object Object],[object Object],[object Object]
NNT ,[object Object],[object Object],[object Object],[object Object],[object Object]
Uncertainty ,[object Object],[object Object],[object Object],[object Object]
Which effect measure for meta-analysis? ,[object Object],[object Object],[object Object]
Meta-analysis in RevMan
Meta-analysis in RevMan  (continued) ,[object Object],[object Object]
Fixed vs Random Effects ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Fixed Effects Analysis in Picture View
Random Effects Analysis in Picture View
Random effects in RevMan 5 ←  DerSimonian and Laird  random effects model
Random effects in RevMan 5  (continued) ←  DerSimonian and Laird  random effects model
Sample Forest plot (RR) ,[object Object]
Meta-analysis for Continuous Data ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Mean Difference (MD) ,[object Object],[object Object]
Standardized Mean Difference (SMD) ,[object Object]
Heterogeneity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
    Clinical and Methodologic Heterogeneity  ,[object Object],[object Object],[object Object]
Statistical Heterogeneity ,[object Object],[object Object]
Q test ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
I 2  Statistic ,[object Object],[object Object],[object Object]
I 2  Statistic  (continued) * Importance of I 2  value depends on: ●  magnitude and direction of effects ●  strength of evidence of heterogeneity - Chi-squared P value, or - I 2  confidence interval Considerable heterogeneity*  75% to 100% May represent substantial heterogeneity* 50% to 90% May represent moderate heterogeneity* 30% to 60% Might not be important 0% to 40% Guide to Interpretation I 2  value
Sample Forest Plot:  Q and I 2
What to do with (Statistical) Heterogeneity ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
What to do with (Statistical) Heterogeneity ,[object Object],[object Object],[object Object],[object Object]
Subgroup and Meta-regression ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Subgroup Analysis
Sensitivity Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Confidence intervals
Confidence intervalsConfidence intervals
Confidence intervalsTanay Tandon
 
6. Categorical data analysis - Chi-Square & Fisher Exact Test
6. Categorical data analysis - Chi-Square & Fisher Exact Test6. Categorical data analysis - Chi-Square & Fisher Exact Test
6. Categorical data analysis - Chi-Square & Fisher Exact TestRazif Shahril
 
Overview of different statistical tests used in epidemiological
Overview of different  statistical tests used in epidemiologicalOverview of different  statistical tests used in epidemiological
Overview of different statistical tests used in epidemiologicalshefali jain
 
Multiple Regression and Logistic Regression
Multiple Regression and Logistic RegressionMultiple Regression and Logistic Regression
Multiple Regression and Logistic RegressionKaushik Rajan
 
General Introduction to Health research (Basic)
General Introduction to Health research (Basic)General Introduction to Health research (Basic)
General Introduction to Health research (Basic)Public Health Update
 
Sample size calculation for cohort studies
Sample size calculation for cohort studies Sample size calculation for cohort studies
Sample size calculation for cohort studies Subhashini N
 
Causal Inference PowerPoint
Causal Inference PowerPointCausal Inference PowerPoint
Causal Inference PowerPointemphemory
 
Sample size calculation
Sample  size calculationSample  size calculation
Sample size calculationSwati Singh
 
Intent-to-Treat (ITT) Analysis in Randomized Clinical Trials
Intent-to-Treat (ITT) Analysis in Randomized Clinical TrialsIntent-to-Treat (ITT) Analysis in Randomized Clinical Trials
Intent-to-Treat (ITT) Analysis in Randomized Clinical TrialsMike LaValley
 
Meta analysis
Meta analysisMeta analysis
Meta analysisSethu S
 

What's hot (20)

Confidence intervals
Confidence intervalsConfidence intervals
Confidence intervals
 
6. Categorical data analysis - Chi-Square & Fisher Exact Test
6. Categorical data analysis - Chi-Square & Fisher Exact Test6. Categorical data analysis - Chi-Square & Fisher Exact Test
6. Categorical data analysis - Chi-Square & Fisher Exact Test
 
Overview of different statistical tests used in epidemiological
Overview of different  statistical tests used in epidemiologicalOverview of different  statistical tests used in epidemiological
Overview of different statistical tests used in epidemiological
 
Multiple Regression and Logistic Regression
Multiple Regression and Logistic RegressionMultiple Regression and Logistic Regression
Multiple Regression and Logistic Regression
 
Hazard ratios
Hazard ratiosHazard ratios
Hazard ratios
 
General Introduction to Health research (Basic)
General Introduction to Health research (Basic)General Introduction to Health research (Basic)
General Introduction to Health research (Basic)
 
Sample size calculation for cohort studies
Sample size calculation for cohort studies Sample size calculation for cohort studies
Sample size calculation for cohort studies
 
Sample size calculations
Sample size calculationsSample size calculations
Sample size calculations
 
Bias in clinical research
Bias in clinical research Bias in clinical research
Bias in clinical research
 
Causal Inference PowerPoint
Causal Inference PowerPointCausal Inference PowerPoint
Causal Inference PowerPoint
 
Types of bias
Types of biasTypes of bias
Types of bias
 
Cross sectional study
Cross sectional studyCross sectional study
Cross sectional study
 
Metaanalysis copy
Metaanalysis    copyMetaanalysis    copy
Metaanalysis copy
 
Meta analysis
Meta analysisMeta analysis
Meta analysis
 
Sample Size Determination
Sample Size DeterminationSample Size Determination
Sample Size Determination
 
Sample size calculation
Sample  size calculationSample  size calculation
Sample size calculation
 
Intent-to-Treat (ITT) Analysis in Randomized Clinical Trials
Intent-to-Treat (ITT) Analysis in Randomized Clinical TrialsIntent-to-Treat (ITT) Analysis in Randomized Clinical Trials
Intent-to-Treat (ITT) Analysis in Randomized Clinical Trials
 
Bias and confounder
Bias and confounderBias and confounder
Bias and confounder
 
Meta analysis
Meta analysisMeta analysis
Meta analysis
 
Odds ratio
Odds ratioOdds ratio
Odds ratio
 

Similar to Analysis and Interpretation

Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011NES
 
Biostatistics clinical research & trials
Biostatistics clinical research & trialsBiostatistics clinical research & trials
Biostatistics clinical research & trialseclinicaltools
 
Baker esni handouts slides
Baker esni handouts slidesBaker esni handouts slides
Baker esni handouts slidesBartsMSBlog
 
Baker esni handouts reading papers
Baker esni handouts reading papersBaker esni handouts reading papers
Baker esni handouts reading papersBartsMSBlog
 
bio statistics for clinical research
bio statistics for clinical researchbio statistics for clinical research
bio statistics for clinical researchRanjith Paravannoor
 
Introduction_klsfnsfsnfsgnkgni _to_meta-analysis.ppt
Introduction_klsfnsfsnfsgnkgni _to_meta-analysis.pptIntroduction_klsfnsfsnfsgnkgni _to_meta-analysis.ppt
Introduction_klsfnsfsnfsgnkgni _to_meta-analysis.pptAnnaMarieAndalRanill
 
Sample Size Estimation and Statistical Test Selection
Sample Size Estimation  and Statistical Test SelectionSample Size Estimation  and Statistical Test Selection
Sample Size Estimation and Statistical Test SelectionVaggelis Vergoulas
 
2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - Final2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - FinalBrian Lin
 
Analytic Methods and Issues in CER from Observational Data
Analytic Methods and Issues in CER from Observational DataAnalytic Methods and Issues in CER from Observational Data
Analytic Methods and Issues in CER from Observational DataCTSI at UCSF
 
Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015Isla Kuhn
 
Importance of evidence
Importance of evidenceImportance of evidence
Importance of evidencesahughes
 
Research methods 2 operationalization &amp; measurement
Research methods 2   operationalization &amp; measurementResearch methods 2   operationalization &amp; measurement
Research methods 2 operationalization &amp; measurementattique1960
 
Quantitative_analysis.ppt
Quantitative_analysis.pptQuantitative_analysis.ppt
Quantitative_analysis.pptmousaderhem1
 
25_Anderson_Biostatistics_and_Epidemiology.ppt
25_Anderson_Biostatistics_and_Epidemiology.ppt25_Anderson_Biostatistics_and_Epidemiology.ppt
25_Anderson_Biostatistics_and_Epidemiology.pptPriyankaSharma89719
 
Overview Of Ich New E9
Overview Of Ich New E9Overview Of Ich New E9
Overview Of Ich New E9Jay1818mar
 

Similar to Analysis and Interpretation (20)

Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011Critical Appriaisal Skills Basic 1 | May 4th 2011
Critical Appriaisal Skills Basic 1 | May 4th 2011
 
Biostatistics clinical research & trials
Biostatistics clinical research & trialsBiostatistics clinical research & trials
Biostatistics clinical research & trials
 
Baker esni handouts slides
Baker esni handouts slidesBaker esni handouts slides
Baker esni handouts slides
 
Baker esni handouts reading papers
Baker esni handouts reading papersBaker esni handouts reading papers
Baker esni handouts reading papers
 
bio statistics for clinical research
bio statistics for clinical researchbio statistics for clinical research
bio statistics for clinical research
 
Introduction_klsfnsfsnfsgnkgni _to_meta-analysis.ppt
Introduction_klsfnsfsnfsgnkgni _to_meta-analysis.pptIntroduction_klsfnsfsnfsgnkgni _to_meta-analysis.ppt
Introduction_klsfnsfsnfsgnkgni _to_meta-analysis.ppt
 
Sample Size Estimation and Statistical Test Selection
Sample Size Estimation  and Statistical Test SelectionSample Size Estimation  and Statistical Test Selection
Sample Size Estimation and Statistical Test Selection
 
Meta analysis with R
Meta analysis with RMeta analysis with R
Meta analysis with R
 
2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - Final2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - Final
 
Analytic Methods and Issues in CER from Observational Data
Analytic Methods and Issues in CER from Observational DataAnalytic Methods and Issues in CER from Observational Data
Analytic Methods and Issues in CER from Observational Data
 
Bgy5901
Bgy5901Bgy5901
Bgy5901
 
Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015Quantitative critical appraisal october 2015
Quantitative critical appraisal october 2015
 
Displaying your results
Displaying your resultsDisplaying your results
Displaying your results
 
Bias and validity
Bias and validityBias and validity
Bias and validity
 
Importance of evidence
Importance of evidenceImportance of evidence
Importance of evidence
 
Research methods 2 operationalization &amp; measurement
Research methods 2   operationalization &amp; measurementResearch methods 2   operationalization &amp; measurement
Research methods 2 operationalization &amp; measurement
 
Quantitative_analysis.ppt
Quantitative_analysis.pptQuantitative_analysis.ppt
Quantitative_analysis.ppt
 
Session1b.ppt
Session1b.pptSession1b.ppt
Session1b.ppt
 
25_Anderson_Biostatistics_and_Epidemiology.ppt
25_Anderson_Biostatistics_and_Epidemiology.ppt25_Anderson_Biostatistics_and_Epidemiology.ppt
25_Anderson_Biostatistics_and_Epidemiology.ppt
 
Overview Of Ich New E9
Overview Of Ich New E9Overview Of Ich New E9
Overview Of Ich New E9
 

More from Francisco J Grajales III

Patient perspectives on (an)onymous data sharing
Patient perspectives on (an)onymous data sharingPatient perspectives on (an)onymous data sharing
Patient perspectives on (an)onymous data sharingFrancisco J Grajales III
 
Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...
Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...
Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...Francisco J Grajales III
 
Multi-User Virtual Environments in Healthcare: A Primer for Healthcare Students
Multi-User Virtual Environments in Healthcare: A Primer for Healthcare StudentsMulti-User Virtual Environments in Healthcare: A Primer for Healthcare Students
Multi-User Virtual Environments in Healthcare: A Primer for Healthcare StudentsFrancisco J Grajales III
 
Pianissisimo: A Primer on Communicating with Decision Makers
Pianissisimo: A Primer on Communicating with Decision Makers Pianissisimo: A Primer on Communicating with Decision Makers
Pianissisimo: A Primer on Communicating with Decision Makers Francisco J Grajales III
 
Las TIC y la Sanidad 2.0: Al infinito y mas allá
Las TIC y la Sanidad 2.0: Al infinito y mas alláLas TIC y la Sanidad 2.0: Al infinito y mas allá
Las TIC y la Sanidad 2.0: Al infinito y mas alláFrancisco J Grajales III
 
To tweet or not to tweet? : Exploring the use of Social Media for [public] he...
To tweet or not to tweet? : Exploring the use of Social Media for [public] he...To tweet or not to tweet? : Exploring the use of Social Media for [public] he...
To tweet or not to tweet? : Exploring the use of Social Media for [public] he...Francisco J Grajales III
 
Perceptions and attitudes toward virtual-reality medical training: The Ann My...
Perceptions and attitudes toward virtual-reality medical training: The Ann My...Perceptions and attitudes toward virtual-reality medical training: The Ann My...
Perceptions and attitudes toward virtual-reality medical training: The Ann My...Francisco J Grajales III
 
E-Government and E-Health Strategies by Mrs. Veronica Boateng
E-Government and E-Health Strategies by Mrs. Veronica BoatengE-Government and E-Health Strategies by Mrs. Veronica Boateng
E-Government and E-Health Strategies by Mrs. Veronica BoatengFrancisco J Grajales III
 
eHealth : the promise of ICT for improving health in Africa
eHealth : the promise of ICT for improving health in AfricaeHealth : the promise of ICT for improving health in Africa
eHealth : the promise of ICT for improving health in AfricaFrancisco J Grajales III
 
ICT Infrastructure in Africa and the uptake of e-Health
ICT Infrastructure in Africa and the uptake of e-HealthICT Infrastructure in Africa and the uptake of e-Health
ICT Infrastructure in Africa and the uptake of e-HealthFrancisco J Grajales III
 
Electronic Health Records Global Perspectives
Electronic Health Records Global PerspectivesElectronic Health Records Global Perspectives
Electronic Health Records Global PerspectivesFrancisco J Grajales III
 
Interoperability Standards: The Key to Mobile Data
Interoperability Standards:The Key to Mobile DataInteroperability Standards:The Key to Mobile Data
Interoperability Standards: The Key to Mobile DataFrancisco J Grajales III
 
Public Health Informatics in Africa Examples from IDRC supported projects in ...
Public Health Informatics in Africa Examples from IDRC supported projects in ...Public Health Informatics in Africa Examples from IDRC supported projects in ...
Public Health Informatics in Africa Examples from IDRC supported projects in ...Francisco J Grajales III
 
Role of standards, consumer education and media literacy
Role of standards, consumer education and media literacyRole of standards, consumer education and media literacy
Role of standards, consumer education and media literacyFrancisco J Grajales III
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Francisco J Grajales III
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Francisco J Grajales III
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Francisco J Grajales III
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Francisco J Grajales III
 

More from Francisco J Grajales III (20)

Patient perspectives on (an)onymous data sharing
Patient perspectives on (an)onymous data sharingPatient perspectives on (an)onymous data sharing
Patient perspectives on (an)onymous data sharing
 
Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...
Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...
Using Social Media in (Evidence-Based Emergency) Medicine: A Primer for Pract...
 
Multi-User Virtual Environments in Healthcare: A Primer for Healthcare Students
Multi-User Virtual Environments in Healthcare: A Primer for Healthcare StudentsMulti-User Virtual Environments in Healthcare: A Primer for Healthcare Students
Multi-User Virtual Environments in Healthcare: A Primer for Healthcare Students
 
Pianissisimo: A Primer on Communicating with Decision Makers
Pianissisimo: A Primer on Communicating with Decision Makers Pianissisimo: A Primer on Communicating with Decision Makers
Pianissisimo: A Primer on Communicating with Decision Makers
 
Las TIC y la Sanidad 2.0: Al infinito y mas allá
Las TIC y la Sanidad 2.0: Al infinito y mas alláLas TIC y la Sanidad 2.0: Al infinito y mas allá
Las TIC y la Sanidad 2.0: Al infinito y mas allá
 
Panorama Internacional del eHealth
Panorama Internacional del eHealthPanorama Internacional del eHealth
Panorama Internacional del eHealth
 
To tweet or not to tweet? : Exploring the use of Social Media for [public] he...
To tweet or not to tweet? : Exploring the use of Social Media for [public] he...To tweet or not to tweet? : Exploring the use of Social Media for [public] he...
To tweet or not to tweet? : Exploring the use of Social Media for [public] he...
 
Perceptions and attitudes toward virtual-reality medical training: The Ann My...
Perceptions and attitudes toward virtual-reality medical training: The Ann My...Perceptions and attitudes toward virtual-reality medical training: The Ann My...
Perceptions and attitudes toward virtual-reality medical training: The Ann My...
 
Forumclinic Reshape 09
Forumclinic Reshape 09Forumclinic Reshape 09
Forumclinic Reshape 09
 
E-Government and E-Health Strategies by Mrs. Veronica Boateng
E-Government and E-Health Strategies by Mrs. Veronica BoatengE-Government and E-Health Strategies by Mrs. Veronica Boateng
E-Government and E-Health Strategies by Mrs. Veronica Boateng
 
eHealth : the promise of ICT for improving health in Africa
eHealth : the promise of ICT for improving health in AfricaeHealth : the promise of ICT for improving health in Africa
eHealth : the promise of ICT for improving health in Africa
 
ICT Infrastructure in Africa and the uptake of e-Health
ICT Infrastructure in Africa and the uptake of e-HealthICT Infrastructure in Africa and the uptake of e-Health
ICT Infrastructure in Africa and the uptake of e-Health
 
Electronic Health Records Global Perspectives
Electronic Health Records Global PerspectivesElectronic Health Records Global Perspectives
Electronic Health Records Global Perspectives
 
Interoperability Standards: The Key to Mobile Data
Interoperability Standards:The Key to Mobile DataInteroperability Standards:The Key to Mobile Data
Interoperability Standards: The Key to Mobile Data
 
Public Health Informatics in Africa Examples from IDRC supported projects in ...
Public Health Informatics in Africa Examples from IDRC supported projects in ...Public Health Informatics in Africa Examples from IDRC supported projects in ...
Public Health Informatics in Africa Examples from IDRC supported projects in ...
 
Role of standards, consumer education and media literacy
Role of standards, consumer education and media literacyRole of standards, consumer education and media literacy
Role of standards, consumer education and media literacy
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...
 
Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...Quality and safety of health information on the Internet: Who decides and ho...
Quality and safety of health information on the Internet: Who decides and ho...
 

Recently uploaded

Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusZilliz
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businesspanagenda
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistandanishmna97
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelDeepika Singh
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoffsammart93
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Zilliz
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native ApplicationsWSO2
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Victor Rentea
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKJago de Vreede
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesrafiqahmad00786416
 
AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)
AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)
AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)Samir Dash
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 

Recently uploaded (20)

Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot ModelMcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Mcleodganj Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)Introduction to Multilingual Retrieval Augmented Generation (RAG)
Introduction to Multilingual Retrieval Augmented Generation (RAG)
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)
AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)
AI+A11Y 11MAY2024 HYDERBAD GAAD 2024 - HelloA11Y (11 May 2024)
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..Understanding the FAA Part 107 License ..
Understanding the FAA Part 107 License ..
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 

Analysis and Interpretation

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. Risk ratio (RR) aka relative risk RR = a / (a+b) c / (c+d) Risk/ probability/ chance of the occurrence of an event in treatment relative to control Intervention Control a+b=n I c+d=n C Event No event d c b a
  • 8. Sample RR Calculation Death No death RR = 14/133 = 0.11 = 0.13 128/148 0.86 Drug 133 148 Placebo 20 128 119 14
  • 9. Odds ratio (OR) Intervention Control No event Event OR = a / b c / d Odds of an event occurring to it not occurring for treatment relative to control a+b=n I c+d=n C d c b a
  • 10. Sample OR Calculation Death No death Drug Placebo 133 148 OR = 14/119 = 0.12 = 0.019 128/20 6.4 20 128 119 14
  • 11. Interpreting (for intervention) Increased odds (harmful) Increased odds (beneficial) OR>1 (6.4/0.12) Reduced odds (beneficial) Reduced odds (not beneficial) OR<1 (0.12/6.4) No difference No difference OR=1, RR=1 Increased risk (harmful) Increased risk (beneficial) RR>1 (0.86/0.11) Reduced risk (beneficial) Reduced risk (not beneficial) RR<1 (0.11/0.86) Bad outcome (e.g. infection) Good outcome (e.g. remission)
  • 12.
  • 13. Closer Look at Odds RR = 0.11 / 0.86 = 0.13 ↑ A rate (11%) OR = 0.12 / 6.4 = 0.019 ↑ ~1:9 ↑ ~7:1
  • 14.
  • 15. Risk Difference (RD) Death No death Actual difference in risk of events Placebo Drug 133 148 RD = 14/133 – 128/148 = 0.11 – 0.86 = - 0.75 20 128 119 14
  • 16.
  • 17.
  • 18.
  • 19.
  • 21.
  • 22.
  • 23. Fixed Effects Analysis in Picture View
  • 24. Random Effects Analysis in Picture View
  • 25. Random effects in RevMan 5 ← DerSimonian and Laird random effects model
  • 26. Random effects in RevMan 5 (continued) ← DerSimonian and Laird random effects model
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36. I 2 Statistic (continued) * Importance of I 2 value depends on: ● magnitude and direction of effects ● strength of evidence of heterogeneity - Chi-squared P value, or - I 2 confidence interval Considerable heterogeneity* 75% to 100% May represent substantial heterogeneity* 50% to 90% May represent moderate heterogeneity* 30% to 60% Might not be important 0% to 40% Guide to Interpretation I 2 value
  • 37. Sample Forest Plot: Q and I 2
  • 38.
  • 39.
  • 40.
  • 42.